市場調査レポート
商品コード
1072794

POC分子診断の世界市場(2022年~2026年)

Global POC Molecular Diagnostics Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
POC分子診断の世界市場(2022年~2026年)
出版日: 2022年05月04日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のPOC分子診断の市場規模は、2022年から2026年の予測期間中に14.67%のCAGRで推移し、18億3,000万米ドルの成長が見込まれています。

同市場の成長を後押しする主な要因には、高齢者人口の増加、ゲノミクスおよびプロテオミクスにおけるマイクロアレイの採用の増加、個別化医療への注目の高まりなどが挙げられます。

当レポートでは、世界のPOC分子診断市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、製品・用途・地域別の分析、さらにベンダー情勢およびベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年から2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースサマリー
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバル関係の脅威
  • 市況

第5章 製品別の市場内訳

  • 市場内訳
  • 製品別の比較
  • PCR:市場規模と予測(2021年~2026年)
  • マイクロアレイとハイブリダイゼーション:市場規模と予測(2021年~2026年)
  • 製品別の市場機会

第6章 用途別市場内訳

  • 市場内訳
  • 用途別比較
  • 感染症:市場規模と予測(2021年~2026年)
  • 腫瘍学:市場規模と予測(2021年~2026年)
  • 血液学および内分泌学:市場規模および予測(2021年~2026年)
  • その他:市場規模と予測(2021年~2026年)
  • 用途別の市場機会

第7章 顧客情勢

  • 顧客情勢の概要

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • 中国:市場規模と予測(2021年~2026年)
  • フランス:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第9章 成長要因、課題、動向

  • 市場促進要因
  • 市場の課題
  • 成長要因と課題の影響
  • 市場動向

第10章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱情勢
  • 業界のリスク

第11章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • QIAGEN NV
  • QuantuMDx Group Ltd.
  • Quidel Corp.
  • Robert Bosch GmbH
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第12章 付録

  • 調査範囲
  • 包含および除外チェックリスト
  • 米ドルの為替レート
  • 調査手法
  • 略語のリスト

図表:

  • 図表1:エグゼクティブサマリー:市場概要のチャート
  • 図表2:エグゼクティブサマリー:市場概要に関するデータテーブル
  • 図表3:エグゼクティブサマリー:世界市場の特徴に関するチャート
  • 図表4:エグゼクティブサマリー:地域別情勢の市場チャート
  • 図表5:エグゼクティブサマリー:製品別の市場内訳に関するチャート
  • 図表6:エグゼクティブサマリー:用途別の市場内訳に関するチャート
  • 図表7:エグゼクティブサマリー:増分成長に関するチャート
  • 図表8:エグゼクティブサマリー:増分成長に関するデータテーブル
  • 図表9:エグゼクティブサマリー:ベンダー市場のポジショニングに関するチャート
  • 図表10:親市場
  • 図表11:市場の特徴
  • 図表12:市場定義に含まれるベンダーの提供
  • 図表13:市場セグメント
  • 図表14:世界のチャート:市場規模と予測(2021年~2026年)
  • 図表15:世界に関するデータ表:市場規模と予測(2021年~2026年)
  • 図表16:世界市場のチャート:前年比成長率(2021年~2026年)
  • 図表17:世界市場のデータ表:前年比成長(2021年~2026年)
  • 図表18:ファイブフォース分析:2021年と2026年の比較
  • 図表19:買い手の交渉力に関するチャート:2021年と2026年の主要な要因の影響
  • 図表20:供給企業の交渉力:2021年と2026年の主要な要因の影響
  • 図表21:新規参入業者の脅威:2021年と2026年の主要な要因の影響
  • 図表22:代替品の脅威:2021年と2026年の主要な要因の影響
  • 図表23:競争の脅威:2021年と2026年の主要な要因の影響
  • 図表24:市況のチャート:2021年と2026年の5つの力
  • 図表25:製品のチャート:市場シェア(2021年~2026年)
  • 図表26:製品のデータ表:市場シェア(2021年~2026年)
  • 図表27:製品別比較表
  • 図表28:製品別の比較に関するデータ表
  • 図表29:PCRのチャート:市場規模と予測(2021年~2026年)
  • 図表30:PCRに関するデータ表:市場規模と予測(2021年~2026年)
  • 図表31:PCRのチャート:前年比成長(2021年~2026年)
  • 図表32:PCRに関するデータ表:前年比成長率(2021年~2026年)
  • 図表33:マイクロアレイとハイブリダイゼーションに関するチャート:市場規模と予測(2021年~2026年)
  • 図表34:マイクロアレイとハイブリダイゼーションに関するデータ表:市場規模と予測(2021年~2026年)
  • 図表35:マイクロアレイとハイブリダイゼーションのチャート:前年比成長(2021年~2026年)
  • 図表36:マイクロアレイとハイブリダイゼーションに関するデータ表:前年比成長率(2021年~2026年)
  • 図表37:製品別の市場機会
  • 図表38:用途のチャート:市場シェア(2021年~2026年)
  • 図表39:用途のデータ表:市場シェア(2021年~2026年)
  • 図表40:用途別比較チャート
  • 図表41:用途別の比較に関するデータ表
  • 図表42:感染症に関するチャート:市場規模と予測(2021年~2026年)
  • 図表43:感染症に関するデータ表:市場規模と予測(2021年~2026年)
  • 図表44:感染症に関するチャート:前年比成長率(2021年~2026年)
  • 図表45:感染症に関するデータ表:前年比成長率(2021年~2026年)
  • 図表46:腫瘍学のチャート:市場規模と予測(2021年~2026年)
  • 図表47:腫瘍学に関するデータ表:市場規模と予測(2021年~2026年)
  • 図表48:腫瘍学のチャート:前年比成長(2021年~2026年)
  • 図表49:腫瘍学に関するデータ表:前年比成長率(2021年~2026年)
  • 図表50:血液学および内分泌学のチャート:市場規模および予測(2021年~2026年)
  • 図表51:血液学および内分泌学に関するデータ表:市場規模および予測(2021年~2026年)
  • 図表52:血液学および内分泌学のチャート:前年比成長(2021年~2026年)
  • 図表53:血液学および内分泌学に関するデータ表:前年比成長率(2021年~2026年)
  • 図表54:その他のチャート:市場規模と予測(2021年~2026年)
  • 図表55:その他のデータ表:市場規模と予測(2021年~2026年)
  • 図表56:その他のチャート:前年比成長率(2021年~2026年)
  • 図表57:その他のデータ表:前年比成長率(2021年~2026年)
  • 図表58:用途別の市場機会(百万米ドル)
  • 図表59:価格感応度、ライフサイクル、顧客購入バスケット、採用率、購入基準の分析
  • 図表60:地域情勢別の市場シェアのチャート(%)(2021年~2026年)
  • 図表61:地域情勢別の市場シェアのデータ表(%)(2021年~2026年)
  • 図表62:地域別比較のチャート
  • 図表63:地域別比較に関するデータ表
  • 図表64:北米のチャート:市場規模と予測(2021年~2026年)
  • 図表65:北米のデータ表:市場規模と予測(2021年~2026年)
  • 図表66:北米のチャート:前年比成長率(2021年~2026年)
  • 図表67:北米のデータ表:前年比成長率(2021年~2026年)
  • 図表68:欧州のチャート:市場規模と予測(2021年~2026年)
  • 図表69:欧州のデータ表:市場規模と予測(2021年~2026年)
  • 図表70:欧州のチャート:前年比成長率(2021年~2026年)
  • 図表71:欧州のデータ表:前年比成長率(2021年~2026年)
  • 図表72:アジアのチャート:市場規模と予測(2021年~2026年)
  • 図表73:アジアのデータ表:市場規模と予測(2021年~2026年)
  • 図表74:アジアのチャート:前年比成長率(2021年~2026年)
  • 図表75:アジアのデータ表:前年比成長率(2021年~2026年)
  • 図表76:その他の地域のチャート:市場規模と予測(2021年~2026年)
  • 図表77:その他の地域のデータテーブル:市場規模と予測(2021年~2026年)
  • 図表78:その他の地域のチャート:前年比成長率(2021年~2026年)
  • 図表79:その他の地域のデータ表:前年比成長率(2021年~2026年)
  • 図表80:米国のチャート:市場規模と予測(2021年~2026年)
  • 図表81:米国のデータ表:市場規模と予測(2021年~2026年)
  • 図表82:米国のチャート:前年比成長(2021年~2026年)
  • 図表83:米国のデータ表:前年比成長率(2021年~2026年)
  • 図表84:ドイツのチャート:市場規模と予測(2021年~2026年)
  • 図表85:ドイツのデータテーブル:市場規模と予測(2021年~2026年)
  • 図表86:ドイツのチャート:前年比成長率(2021年~2026年)
  • 図表87:ドイツのデータ表:前年比成長率(2021年~2026年)
  • 図表88:カナダのチャート:市場規模と予測(2021年~2026年)
  • 図表89:カナダのデータ表:市場規模と予測(2021年~2026年)
  • 図表90:カナダのチャート:前年比成長率(2021年~2026年)
  • 図表91:カナダのデータ表:前年比成長率(2021年~2026年)
  • 図表92:中国のチャート:市場規模と予測(2021年~2026年)
  • 図表93:中国のデータ表:市場規模と予測(2021年~2026年)
  • 図表94:中国のチャート:前年比成長率(2021年~2026年)
  • 図表95:中国のデータ表:前年比成長率(2021年~2026年)
  • 図表96:フランスのチャート:市場規模と予測(2021年~2026年)
  • 図表97:フランスのデータテーブル:市場規模と予測(2021年~2026年)
  • 図表98:フランスのチャート:前年比成長率(2021年~2026年)
  • 図表99:フランスのデータ表:前年比成長率(2021年~2026年)
  • 図表100:地域情勢別の市場機会
  • 図表101:2021年と2026年の成長要因と課題の影響
  • 図表102:インプットの重要性と差別化の要因に関する概要
  • 図表103:混乱の要因の概要
  • 図表104:主要なリスクがビジネスに与える影響
  • 図表105:対象ベンダー
  • 図表106:ベンダーの位置と分類に関するマトリックス
  • 図表107:Abbott Laboratories:概要
  • 図表108:Abbott Laboratories:事業セグメント
  • 図表109:Abbott Laboratories:重要なニュース
  • 図表110:Abbott Laboratories:主な製品
  • 図表111:Abbott Laboratories:セグメントフォーカス
  • 図表112:bioMerieux SA:概要
  • 図表113:bioMerieux SA:事業セグメント
  • 図表114:bioMerieux SA:主な製品
  • 図表115:bioMerieux SA:セグメントフォーカス
  • 図表116:Danaher Corp.:概要
  • 図表117:Danaher Corp.:事業セグメント
  • 図表118:Danaher Corp.:重要なニュース
  • 図表119:Danaher Corp.:主な製品
  • 図表120:Danaher Corp.:セグメントフォーカス
  • 図表121:F. Hoffmann La Roche Ltd.:概要
  • 図表122:F. Hoffmann La Roche Ltd.:事業セグメント
  • 図表123:F. Hoffmann La Roche Ltd.:重要なニュース
  • 図表124:F. Hoffmann La Roche Ltd.:主な製品
  • 図表125:F. Hoffmann La Roche Ltd.:セグメントフォーカス
  • 図表126:QIAGEN NV:概要
  • 図表127:QIAGEN NV:製品/サービス
  • 図表128:QIAGEN NV:重要なニュース
  • 図表129:QIAGEN NV:主な製品
  • 図表130:QuantuMDx Group Ltd.:概要
  • 図表131:QuantuMDx Group Ltd.:製品/サービス
  • 図表132:QuantuMDx Group Ltd.:主な製品
  • 図表133:Quidel Corp.:概要
  • 図表134:Quidel Corp.:製品/サービス
  • 図表135:Quidel Corp.:主な製品
  • 図表136:Robert Bosch GmbH:概要
  • 図表137:Robert Bosch GmbH:事業セグメント
  • 図表138:Robert Bosch GmbH:重要なニュース
  • 図表139:Robert Bosch GmbH:主な製品
  • 図表140:Robert Bosch GmbH:セグメントフォーカス
  • 図表141:Siemens AG:概要
  • 図表142:Siemens AG:事業セグメント
  • 図表143:Siemens AG:重要なニュース
  • 図表144:Siemens AG:主な製品
  • 図表145:Siemens AG:セグメントの焦点
  • 図表146:Thermo Fisher Scientific Inc.:概要
  • 図表147:Thermo Fisher Scientific Inc.:事業セグメント
  • 図表148:Thermo Fisher Scientific Inc.:重要なニュース
  • 図表149:Thermo Fisher Scientific Inc.:主な製品
  • 図表150:Thermo Fisher Scientific Inc.:セグメントフォーカス
  • 図表151:包含チェックリスト
  • 図表152:除外チェックリスト
  • 図表153:米ドルの為替レート
  • 図表154:調査手法
  • 図表155:市場のサイジングに採用された検証手法
  • 図表156:情報源
  • 図表157:略語のリスト
図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits18: Five forces analysis - Comparison between2021 and 2026
  • Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits23: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits24: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits25: Chart on Product - Market share 2021-2026 (%)
  • Exhibits26: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits27: Chart on Comparison by Product
  • Exhibits28: Data Table on Comparison by Product
  • Exhibits29: Chart on PCR - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Data Table on PCR - Market size and forecast 2021-2026 ($ million)
  • Exhibits31: Chart on PCR - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Data Table on PCR - Year-over-year growth 2021-2026 (%)
  • Exhibits33: Chart on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Data Table on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
  • Exhibits35: Chart on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Data Table on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
  • Exhibits37: Market opportunity by Product ($ million)
  • Exhibits38: Chart on Application - Market share 2021-2026 (%)
  • Exhibits39: Data Table on Application - Market share 2021-2026 (%)
  • Exhibits40: Chart on Comparison by Application
  • Exhibits41: Data Table on Comparison by Application
  • Exhibits42: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Market opportunity by Application ($ million)
  • Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits60: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits62: Chart on Geographic comparison
  • Exhibits63: Data Table on Geographic comparison
  • Exhibits64: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits66: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits67: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits70: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits74: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits80: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits81: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits82: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits83: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits84: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits85: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits86: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits87: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits88: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits89: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits90: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits91: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits92: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits93: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits94: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits95: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits96: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits97: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits98: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits99: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits100: Market opportunity By Geographical Landscape ($ million)
  • Exhibits101: Impact of drivers and challenges in 2021 and 2026
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Abbott Laboratories - Overview
  • Exhibits108: Abbott Laboratories - Business segments
  • Exhibits109: Abbott Laboratories - Key news
  • Exhibits110: Abbott Laboratories - Key offerings
  • Exhibits111: Abbott Laboratories - Segment focus
  • Exhibits112: bioMerieux SA - Overview
  • Exhibits113: bioMerieux SA - Business segments
  • Exhibits114: bioMerieux SA - Key offerings
  • Exhibits115: bioMerieux SA - Segment focus
  • Exhibits116: Danaher Corp. - Overview
  • Exhibits117: Danaher Corp. - Business segments
  • Exhibits118: Danaher Corp. - Key news
  • Exhibits119: Danaher Corp. - Key offerings
  • Exhibits120: Danaher Corp. - Segment focus
  • Exhibits121: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits122: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits123: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits124: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits125: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits126: QIAGEN NV - Overview
  • Exhibits127: QIAGEN NV - Product / Service
  • Exhibits128: QIAGEN NV - Key news
  • Exhibits129: QIAGEN NV - Key offerings
  • Exhibits130: QuantuMDx Group Ltd. - Overview
  • Exhibits131: QuantuMDx Group Ltd. - Product / Service
  • Exhibits132: QuantuMDx Group Ltd. - Key offerings
  • Exhibits133: Quidel Corp. - Overview
  • Exhibits134: Quidel Corp. - Product / Service
  • Exhibits135: Quidel Corp. - Key offerings
  • Exhibits136: Robert Bosch GmbH - Overview
  • Exhibits137: Robert Bosch GmbH - Business segments
  • Exhibits138: Robert Bosch GmbH - Key news
  • Exhibits139: Robert Bosch GmbH - Key offerings
  • Exhibits140: Robert Bosch GmbH - Segment focus
  • Exhibits141: Siemens AG - Overview
  • Exhibits142: Siemens AG - Business segments
  • Exhibits143: Siemens AG - Key news
  • Exhibits144: Siemens AG - Key offerings
  • Exhibits145: Siemens AG - Segment focus
  • Exhibits146: Thermo Fisher Scientific Inc. - Overview
  • Exhibits147: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits148: Thermo Fisher Scientific Inc. - Key news
  • Exhibits149: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits150: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits151: Inclusions checklist
  • Exhibits152: Exclusions checklist
  • Exhibits153: Currency conversion rates for US$
  • Exhibits154: Research methodology
  • Exhibits155: Validation techniques employed for market sizing
  • Exhibits156: Information sources
  • Exhibits157: List of abbreviations
目次
Product Code: IRTNTR45390

Technavio has been monitoring the POC molecular diagnostics market and it is poised to grow by $ 1.83 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our report on the POC molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.

The POC molecular diagnostics market analysis includes the product, application segment, and geographic landscape.

Technavio's POC molecular diagnostics market is segmented as below:

By Product

  • PCR
  • Microarray and hybridization

By Application

  • Infectious diseases
  • Oncology
  • Hematology and endocrinology
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing focus on technological advances as one of the prime reasons driving the POC molecular diagnostics market growth during the next few years. Also, the presence of government funding and a growing number of cancer cases worldwide will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on POC molecular diagnostics market covers the following areas:

  • POC molecular diagnostics market sizing
  • POC molecular diagnostics market forecast
  • POC molecular diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC molecular diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., Binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., gene drive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Also, the POC molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 18: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 25: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 26: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 27: Chart on Comparison by Product
  • Exhibit 28: Data Table on Comparison by Product
  • 5.3 PCR - Market size and forecast 2021-2026
  • Exhibit 29: Chart on PCR - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Data Table on PCR - Market size and forecast 2021-2026 ($ million)
  • Exhibit 31: Chart on PCR - Year-over-year growth 2021-2026 (%)
  • Exhibit 32: Data Table on PCR - Year-over-year growth 2021-2026 (%)
  • 5.4 Microarray and hybridization - Market size and forecast 2021-2026
  • Exhibit 33: Chart on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Data Table on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
  • Exhibit 35: Chart on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
  • Exhibit 36: Data Table on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 37: Market opportunity by Product ($ million)

6 Market Segmentation by Application

  • 6.1 Market segments
  • Exhibit 38: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 39: Data Table on Application - Market share 2021-2026 (%)
  • 6.2 Comparison by Application
  • Exhibit 40: Chart on Comparison by Application
  • Exhibit 41: Data Table on Comparison by Application
  • 6.3 Infectious diseases - Market size and forecast 2021-2026
  • Exhibit 42: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
  • 6.4 Oncology - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Oncology - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
  • 6.5 Hematology and endocrinology - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
  • 6.6 Others - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 6.7 Market opportunity by Application
  • Exhibit 58: Market opportunity by Application ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
  • Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
  • Exhibit 60: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 8.2 Geographic comparison
  • Exhibit 62: Chart on Geographic comparison
  • Exhibit 63: Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2021-2026
  • Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 8.4 Europe - Market size and forecast 2021-2026
  • Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 8.5 Asia - Market size and forecast 2021-2026
  • Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 8.7 US - Market size and forecast 2021-2026
  • Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 8.8 Germany - Market size and forecast 2021-2026
  • Exhibit 84: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 85: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 86: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 87: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 8.9 Canada - Market size and forecast 2021-2026
  • Exhibit 88: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 89: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 90: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 91: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 8.10 China - Market size and forecast 2021-2026
  • Exhibit 92: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 93: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 94: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 95: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 8.11 France - Market size and forecast 2021-2026
  • Exhibit 96: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 97: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 98: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 99: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 8.12 Market opportunity By Geographical Landscape
  • Exhibit 100: Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Trends

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2021 and 2026
  • 9.4 Market trends

10 Vendor Landscape

  • 10.1 Overview
  • 10.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 10.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 10.4 Industry risks
  • Exhibit 104: Impact of key risks on business

11 Vendor Analysis

  • 11.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 11.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 11.3 Abbott Laboratories
  • Exhibit 107: Abbott Laboratories - Overview
  • Exhibit 108: Abbott Laboratories - Business segments
  • Exhibit 109: Abbott Laboratories - Key news
  • Exhibit 110: Abbott Laboratories - Key offerings
  • Exhibit 111: Abbott Laboratories - Segment focus
  • 11.4 bioMerieux SA
  • Exhibit 112: bioMerieux SA - Overview
  • Exhibit 113: bioMerieux SA - Business segments
  • Exhibit 114: bioMerieux SA - Key offerings
  • Exhibit 115: bioMerieux SA - Segment focus
  • 11.5 Danaher Corp.
  • Exhibit 116: Danaher Corp. - Overview
  • Exhibit 117: Danaher Corp. - Business segments
  • Exhibit 118: Danaher Corp. - Key news
  • Exhibit 119: Danaher Corp. - Key offerings
  • Exhibit 120: Danaher Corp. - Segment focus
  • 11.6 F. Hoffmann La Roche Ltd.
  • Exhibit 121: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 122: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 123: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus
  • 11.7 QIAGEN NV
  • Exhibit 126: QIAGEN NV - Overview
  • Exhibit 127: QIAGEN NV - Product / Service
  • Exhibit 128: QIAGEN NV - Key news
  • Exhibit 129: QIAGEN NV - Key offerings
  • 11.8 QuantuMDx Group Ltd.
  • Exhibit 130: QuantuMDx Group Ltd. - Overview
  • Exhibit 131: QuantuMDx Group Ltd. - Product / Service
  • Exhibit 132: QuantuMDx Group Ltd. - Key offerings
  • 11.9 Quidel Corp.
  • Exhibit 133: Quidel Corp. - Overview
  • Exhibit 134: Quidel Corp. - Product / Service
  • Exhibit 135: Quidel Corp. - Key offerings
  • 11.10 Robert Bosch GmbH
  • Exhibit 136: Robert Bosch GmbH - Overview
  • Exhibit 137: Robert Bosch GmbH - Business segments
  • Exhibit 138: Robert Bosch GmbH - Key news
  • Exhibit 139: Robert Bosch GmbH - Key offerings
  • Exhibit 140: Robert Bosch GmbH - Segment focus
  • 11.11 Siemens AG
  • Exhibit 141: Siemens AG - Overview
  • Exhibit 142: Siemens AG - Business segments
  • Exhibit 143: Siemens AG - Key news
  • Exhibit 144: Siemens AG - Key offerings
  • Exhibit 145: Siemens AG - Segment focus
  • 11.12 Thermo Fisher Scientific Inc.
  • Exhibit 146: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 147: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 148: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 149: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 150: Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
  • Exhibit 151: Inclusions checklist
  • Exhibit 152: Exclusions checklist
  • 12.3 Currency conversion rates for US$
  • Exhibit 153: Currency conversion rates for US$
  • 12.4 Research methodology
  • Exhibit 154: Research methodology
  • Exhibit 155: Validation techniques employed for market sizing
  • Exhibit 156: Information sources
  • 12.5 List of abbreviations
  • Exhibit 157: List of abbreviations